Anesth Analg 2007;105:312-315
© 2007 International Anesthesia Research Society
doi: 10.1213/01.ane.0000275185.44796.92
CARDIOVASCULAR ANESTHESIOLOGY
Phenoxybenzamine in the Treatment of Hypoplastic Left Heart Syndrome: A Core Review
Nina A. Guzzetta, MD
From the Department of Anesthesiology, Emory University School of Medicine, Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia.
Address correspondence and reprint requests to Nina A. Guzzetta, MD, Department of Anesthesiology, Emory University School of Medicine, Children's Healthcare of Atlanta at Egleston, 1405 Clifton Road NE, Atlanta, GA 30322. Address e-mail to nina.guzzetta{at}emoryhealthcare.org.
Abstract
Perioperative management of neonates after the Norwood procedure is extremely complex. Limited reserve of the neonatal single ventricle and the parallel arrangement of the pulmonary and systemic circuits result in a tenuous balance between pulmonary and systemic blood flows. Precise manipulations of both pulmonary and systemic vascular resistance are necessary to prevent excessive pulmonary blood flow at the expense of systemic oxygen delivery. An emerging treatment strategy aimed at improving early mortality is the intraoperative administration of phenoxybenzamine, a profound systemic vasodilator. Maximum systemic vasodilation is thought to reduce afterload of the single ventricle and produce a more stable parallel circulation by ameliorating the postoperative fluctuations in systemic vascular resistance. Although this strategy has gained popularity at many centers, it is not without scrutiny. The following review provides an overview of the pharmacology of phenoxybenzamine, the surgical and physiologic implications of the Norwood procedure, and a discussion of the pros and cons of phenoxybenzamine administration.
This article has been cited by other articles:

|
 |

|
 |
 
L. Shekerdemian
Perioperative manipulation of the circulation in children with congenital heart disease
Heart,
August 1, 2009;
95(15):
1286 - 1296.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Stuth
Phenoxybenzamine Is Indicated in Treatment of Hypoplastic Left Heart Syndrome: Pro
Anesth. Analg.,
August 1, 2007;
105(2):
307 - 309.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. DiNardo
Phenoxybenzamine Is Indicated in Treatment of Hypoplastic Left Heart Syndrome: Con
Anesth. Analg.,
August 1, 2007;
105(2):
310 - 311.
[Full Text]
[PDF]
|
 |
|
|